Evaluation of HPV infection helps to direct ALA-PDT of condyloma acuminata

• DOI: 10.1016/j.pdpdt.2023.103696
• Publication Date: 2023-07-08T06:14:37Z
• Authors: Hui Liu; Junxiao Wei; Meizhen Zhong; Meinian Xu; Sining Feng; Xiaoming Peng; Hui Liu; Junpeng Li; Weicheng Song; YiXiu Zhong; Xiaowen Huang; Kang Zeng
• Keywords: Photosensitizing Agents; Photochemotherapy; Condylomata Acuminata; Papillomavirus Infections; Humans; Aminolevulinic Acid; DNA; Papillomaviridae; 3. Good health

Aminolaevulinic acid-mediated photodynamic therapy (ALA-PDT) is increasingly applied for the treatment of condyloma acuminata (CA). However, the determinants for the sessions and end points of ALA-PDT treatment remains unclear. Here, we recorded HPV screening, evaluated the frequency and efficacy of ALA-PDT in different types of CA, in order to individualize ALA-PDT treatment to CA.A total of 227 CA patients with HPV infection and visible warts were recruited. Prior to PDT, visible lesions were removed by radio frequency or microwave. HPV DNA detection were performed before each PDT treatment and at follow-up. Treatment was ended after two consecutive negative HPV DNA detection.Of the 227 patients, 119 patients received ALA-PDT and 116 patients completed all treatments. We found that CA patients with multiple-site infection, intra-luminal infection or multiple-type of HPV infection required more sessions of ALA-PDT. The recurrence rate was 8.62% (10/116). Viral load was significantly lower after six PDT treatments compared to viral load after three PDT treatments. Gender, HPV subtypes and warts location had no significant effect on the recurrence rate.Comprehensive evaluation of HPV infection state helps to individualize ALA-PDT treatment scheme for CA patients and predict the therapeutic efficacy.